Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmunity or lymphoma

Journal of Immunology

Volumn 188, Issue 12, 2012, Pages 5935-5943

  Soond, Dalya R ^a   Garçon, Fabien ^a   Patton, Daniel T ^a   Rolf, Julia ^a   Turner, Martin ^a   Scudamore, Cheryl ^b   Garden, Oliver A ^b   Okkenhaug, Klaus ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD134 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GENE; GENE LOCUS; HOMEOSTASIS; LISTERIA MONOCYTOGENES; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; SPLEEN; THYMOCYTE; TNFRSF4 GENE; WILD TYPE;

ANIMALS; AUTOIMMUNITY; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; GENE KNOCK-IN TECHNIQUES; HOMEOSTASIS; LYMPHOCYTE ACTIVATION; LYMPHOMA; MICE; MICE, TRANSGENIC; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 84862589113     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102116     Document Type: Article

References (62)

1. Castellino, F., and R. N. Germain. 2006. Cooperation between CD4+ and CD8+ T cells: when, where, and how. Annu. Rev. Immunol. 24: 519-540.
2. Crotty, S. 2011. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29: 621-663.
3. Wang, B., H. Fujisawa, L. Zhuang, I. Freed, B. G. Howell, S. Shahid, G. M. Shivji, T. W. Mak, and D. N. Sauder. 2000. CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165: 6783-6790. (Pubitemid 32001144)
4. Muranski, P., and N. P. Restifo. 2009. Adoptive immunotherapy of cancer using CD4(+) T cells. Curr. Opin. Immunol. 21: 200-208.
5. Henrickson, S. E., and U. H. von Andrian. 2007. Single-cell dynamics of T-cell priming. Curr. Opin. Immunol. 19: 249-258. (Pubitemid 46687018)
6. Pepper, M., and M. K. Jenkins. 2011. Origins of CD4(+) effector and central memory T cells. Nat. Immunol. 12: 467-471.
7. Williams, M. A., and M. J. Bevan. 2007. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25: 171-192. (Pubitemid 46697906)
8. Okkenhaug, K., and D. A. Fruman. 2010. PI3Ks in lymphocyte signaling and development. Curr. Top. Microbiol. Immunol. 346: 57-85.
9. Fruman, D. A., and G. Bismuth. 2009. Fine tuning the immune response with PI3K. Immunol. Rev. 228: 253-272.
10. Sinclair, L. V., D. Finlay, C. Feijoo, G. H. Cornish, A. Gray, A. Ager, K. Okkenhaug, T. J. Hagenbeek, H. Spits, and D. A. Cantrell. 2008. Phosphatidylinositol- 3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat. Immunol. 9: 513-521. (Pubitemid 351560520)
11. Okkenhaug, K., A. Bilancio, G. Farjot, H. Priddle, S. Sancho, E. Peskett, W. Pearce, S. E. Meek, A. Salpekar, M. D. Waterfield, et al. 2002. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 297: 1031-1034. (Pubitemid 34856039)
12. Okkenhaug, K., D. T. Patton, A. Bilancio, F. Garçon, W. C. Rowan, and B. Vanhaesebroeck. 2006. The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J. Immunol. 177: 5122-5128. (Pubitemid 44527583)
13. Okkenhaug, K., K. Ali, and B. Vanhaesebroeck. 2007. Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K. Trends Immunol. 28: 80-87. (Pubitemid 46176736)
14. Patton, D. T., F. Garçon, and K. Okkenhaug. 2007. The PI3K p110delta controls T-cell development, differentiation and regulation. Biochem. Soc. Trans. 35: 167-171. (Pubitemid 46596459)
15. Salmond, R. J., J. Emery, K. Okkenhaug, and R. Zamoyska. 2009. MAPK, phosphatidylinositol 3-kinase, and mammalian target of rapamycin pathways converge at the level of ribosomal protein S6 phosphorylation to control metabolic signaling in CD8 T cells. J. Immunol. 183: 7388-7397.
16. Soond, D. R., E. Bjørgo, K. Moltu, V. Q. Dale, D. T. Patton, K. M. Torgersen, F. Galleway, B. Twomey, J. Clark, J. S. Gaston, et al. 2010. PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. Blood 115: 2203-2213.
17. Nombela-Arrieta, C., R. A. Lacalle, M. C. Montoya, Y. Kunisaki, D. Megías, M. Marqués, A. C. Carrera, S. Mañes, Y. Fukui, C. Martínez-A, and J. V. Stein. 2004. Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. Immunity 21: 429-441. (Pubitemid 39208343)
18. Nombela-Arrieta, C., T. R. Mempel, S. F. Soriano, I. Mazo, M. P. Wymann, E. Hirsch, C. Martínez-A, Y. Fukui, U. H. von Andrian, and J. V. Stein. 2007. A central role for DOCK2 during interstitial lymphocyte motility and sphingosine- 1-phosphate-mediated egress. J. Exp. Med. 204: 497-510. (Pubitemid 46457074)
19. Martin, A. L., M. D. Schwartz, S. C. Jameson, and Y. Shimizu. 2008. Selective regulation of CD8 effector T cell migration by the p110 gamma isoform of phosphatidylinositol 3-kinase. J. Immunol. 180: 2081-2088.
20. Thomas, M. S., J. S. Mitchell, C. C. DeNucci, A. L. Martin, and Y. Shimizu. 2008. The p110gamma isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites. J. Leukoc. Biol. 84: 814-823.
21. Barber, D. F., A. Bartolomé, C. Hernandez, J. M. Flores, C. Redondo, C. Fernandez-Arias, M. Camps, T. Rückle, M. K. Schwarz, S. Rodríguez, et al. 2005. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat. Med. 11: 933-935. (Pubitemid 41294437)
22. Smith, L. D., E. S. Hickman, R. V. Parry, J. Westwick, and S. G. Ward. 2007. PI3Kgamma is the dominant isoform involved in migratory responses of human T lymphocytes: effects of ex vivo maintenance and limitations of non-viral delivery of siRNA. Cell. Signal. 19: 2528-2539. (Pubitemid 47542298)
23. Garçon, F., D. T. Patton, J. L. Emery, E. Hirsch, R. Rottapel, T. Sasaki, and K. Okkenhaug. 2008. CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 111: 1464-1471. (Pubitemid 351213434)
24. Rolf, J., S. E. Bell, D. Kovesdi, M. L. Janas, D. R. Soond, L. M. Webb, S. Santinelli, T. Saunders, B. Hebeis, N. Killeen, et al. 2010. Phosphoinositide 3- kinase activity in T cells regulates the magnitude of the germinal center reaction. J. Immunol. 185: 4042-4052.
25. Macintyre, A. N., D. Finlay, G. Preston, L. V. Sinclair, C. M. Waugh, P. Tamas, C. Feijoo, K. Okkenhaug, and D. A. Cantrell. 2011. Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity 34: 224-236.
26. Song, J., S. Salek-Ardakani, P. R. Rogers, M. Cheng, L. Van Parijs, and M. Croft. 2004. The costimulation-regulated duration of PKB activation controls T cell longevity. Nat. Immunol. 5: 150-158. (Pubitemid 38208356)
27. Palomero, T., M. L. Sulis, M. Cortina, P. J. Real, K. Barnes, M. Ciofani, E. Caparros, J. Buteau, K. Brown, S. L. Perkins, et al. 2007. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat. Med. 13: 1203-1210. (Pubitemid 47530629)
28. Astoul, E., C. Edmunds, D. A. Cantrell, and S. G. Ward. 2001. PI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models. Trends Immunol. 22: 490-496. (Pubitemid 32778576)
29. Abraham, R. T., and A.Weiss. 2004. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat. Rev. Immunol. 4: 301-308. (Pubitemid 38478665)
30. Suzuki, A., M. T. Yamaguchi, T. Ohteki, T. Sasaki, T. Kaisho, Y. Kimura, R. Yoshida, A. Wakeham, T. Higuchi, M. Fukumoto, et al. 2001. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14: 523-534. (Pubitemid 32520864)
31. Hagenbeek, T. J., M. Naspetti, F. Malergue, F. Garçon, J. A. Nunès, K. B. Cleutjens, J. Trapman, P. Krimpenfort, and H. Spits. 2004. The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. J. Exp. Med. 200: 883-894. (Pubitemid 39362924)
32. Buckler, J. L., P. T. Walsh, P. M. Porrett, Y. Choi, and L. A. Turka. 2006. Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN. J. Immunol. 177: 4262-4266. (Pubitemid 44469752)
33. Xiao, C., L. Srinivasan, D. P. Calado, H. C. Patterson, B. Zhang, J. Wang, J. M. Henderson, J. L. Kutok, and K. Rajewsky. 2008. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9: 405-414. (Pubitemid 351405110)
34. You, H., M. Pellegrini, K. Tsuchihara, K. Yamamoto, G. Hacker, M. Erlacher, A. Villunger, and T. W. Mak. 2006. FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. J. Exp. Med. 203: 1657-1663. (Pubitemid 44036270)
35. Klinger, M., J. K. Kim, S. A. Chmura, A. Barczak, D. J. Erle, and N. Killeen. 2009. Thymic OX40 expression discriminates cells undergoing strong responses to selection ligands. J. Immunol. 182: 4581-4589.
36. Croft, M. 2010. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu. Rev. Immunol. 28: 57-78.
37. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40. (Pubitemid 28194695)
38. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
39. Shinkai, Y., G. Rathbun, K. P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and F. W. Alt. 1992. RAG-2- deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
40. Trotman, L. C., M. Niki, Z. A. Dotan, J. A. Koutcher, A. Di Cristofano, A. Xiao, A. S. Khoo, P. Roy-Burman, N. M. Greenberg, T. Van Dyke, et al. 2003. Pten dose dictates cancer progression in the prostate. PLoS Biol. 1: E59.
41. Srinivas, S., T. Watanabe, C. S. Lin, C. M. William, Y. Tanabe, T. M. Jessell, and F. Costantini. 2001. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1: 4.
42. Luche, H., O. Weber, T. Nageswara Rao, C. Blum, and H. J. Fehling. 2007. Faithful activation of an extra-bright red fluorescent protein in "knock-in" Crereporter mice ideally suited for lineage tracing studies. Eur. J. Immunol. 37: 43-53. (Pubitemid 46128785)
43. Patton, D. T., M. D. Wilson, W. C. Rowan, D. R. Soond, and K. Okkenhaug. 2011. The PI3K p110d regulates expression of CD38 on regulatory T cells. PLoS ONE 6: e17359.
44. Pearce, E. L., and H. Shen. 2007. Generation of CD8 T cell memory is regulated by IL-12. J. Immunol. 179: 2074-2081.
45. Suzuki, A., J. L. de la Pompa, V. Stambolic, A. J. Elia, T. Sasaki, I. del Barco Barrantes, A. Ho, A. Wakeham, A. Itie, W. Khoo, et al. 1998. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8: 1169-1178.
46. Di Cristofano, A., B. Pesce, C. Cordon-Cardo, and P. P. Pandolfi. 1998. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19: 348-355. (Pubitemid 28357906)
47. Hagenbeek, T. J., and H. Spits. 2008. T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus. Leukemia 22: 608-619. (Pubitemid 351386732)
48. Xue, L., H. Nolla, A. Suzuki, T. W. Mak, and A. Winoto. 2008. Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice. Proc. Natl. Acad. Sci. USA 105: 2022-2027. (Pubitemid 351439458)
49. Liu, X., J. L. Karnell, B. Yin, R. Zhang, J. Zhang, P. Li, Y. Choi, J. S. Maltzman, W. S. Pear, C. H. Bassing, and L. A. Turka. 2010. Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice. J. Clin. Invest. 120: 2497-2507.
50. Walsh, P. T., J. L. Buckler, J. Zhang, A. E. Gelman, N. M. Dalton, D. K. Taylor, S. J. Bensinger, W. W. Hancock, and L. A. Turka. 2006. PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs. J. Clin. Invest. 116: 2521-2531. (Pubitemid 44330151)
51. Buckler, J. L., X. Liu, and L. A. Turka. 2008. Regulation of T-cell responses by PTEN. Immunol. Rev. 224: 239-248.
52. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342. (Pubitemid 36433727)
53. Acuto, O., V. Di Bartolo, and F. Michel. 2008. Tailoring T-cell receptor signals by proximal negative feedback mechanisms. Nat. Rev. Immunol. 8: 699-712.
54. Perona-Wright, G., K. Mohrs, and M. Mohrs. 2010. Sustained signaling by canonical helper T cell cytokines throughout the reactive lymph node. Nat. Immunol. 11: 520-526.
55. Ramadani, F., D. J. Bolland, F. Garcon, J. L. Emery, B. Vanhaesebroeck, A. E. Corcoran, and K. Okkenhaug. 2010. The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development. Sci. Signal. 3: ra60.
56. Barber, D. F., A. Bartolomé, C. Hernandez, J. M. Flores, C. Fernandez-Arias, L. Rodríguez-Borlado, E. Hirsch, M.Wymann, D. Balomenos, and A. C. Carrera. 2006. Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K- induced systemic lupus but not T cell invasion. J. Immunol. 176: 589-593. (Pubitemid 43023307)
57. Berod, L., C. Heinemann, S. Heink, A. Escher, C. Stadelmann, S. Drube, R. Wetzker, J. Norgauer, and T. Kamradt. 2011. PI3Kγ deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome. Eur. J. Immunol. 41: 833-844.
58. Guo, W., S. Schubbert, J. Y. Chen, B. Valamehr, S. Mosessian, H. Shi, N. H. Dang, C. Garcia, M. F. Theodoro, M. Varella-Garcia, and H. Wu. 2011. Suppression of leukemia development caused by PTEN loss. Proc. Natl. Acad. Sci. USA 108: 1409-1414.
59. Newrzela, S., K. Cornils, Z. Li, C. Baum, M. H. Brugman, M. Hartmann, J. Meyer, S. Hartmann, M. L. Hansmann, B. Fehse, and D. von Laer. 2008. Resistance of mature T cells to oncogene transformation. Blood 112: 2278-2286.
60. Antony, P. A., C. A. Piccirillo, A. Akpinarli, S. E. Finkelstein, P. J. Speiss, D. R. Surman, D. C. Palmer, C. C. Chan, C. A. Klebanoff, W. W. Overwijk, et al. 2005. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J. Immunol. 174: 2591-2601. (Pubitemid 40279672)
61. Xie, Y., A. Akpinarli, C. Maris, E. L. Hipkiss, M. Lane, E. K. Kwon, P. Muranski, N. P. Restifo, and P. A. Antony. 2010. Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J. Exp. Med. 207:651-667.
62. Shafer-Weaver, K. A., S. K. Watkins, M. J. Anderson, L. J. Draper, A. Malyguine, W. G. Alvord, N. M. Greenberg, and A. A. Hurwitz. 2009. Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells. Cancer Res. 69: 6256-6264.